Sosei Group Investor
Sosei is a Japanese biopharmaceutical company that develops and commercializes innovative drugs.
Technology:
Others
Industry:
Longevity Industry 2022
Headquarters:
Tokyo, Tokyo, Japan
Founded Date:
01 06 90
Employees Number:
ноя 50
Funding Status:
IPO
Investor Type:
For Profit
Number Of Exits:
1
Acquisitions Number:
2
Investors Number:
7
Total Funding:
265028950
Last Funding Date:
16 07 20
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership